首页> 中文期刊> 《中国卫生标准管理》 >CT诊断中心型肺癌的准确性及MRI补充诊断的临床意义分析

CT诊断中心型肺癌的准确性及MRI补充诊断的临床意义分析

         

摘要

Objective To explore the accuracy of CT diagnosis of central type of lung cancer,and to make a comprehensive analysis of the clinical significance of MRI supplement. Methods Selected the 150 cases of central lung cancer patients that were treated in our hospital as the study from March 2,2015 to November 2,2015,al patients were taken CT diagnosis. On the basis of CT examination of the patient using MRI supplement diagnosis,the accuracy of two different diagnostic methods were compared. Results Only the patients were diagnosed with CT,the accuracy rate was 79.35%. On this basis,the patients were diagnosed with MRI,and the accuracy was 94.62%. The diagnostic accuracy of MRI was significantly higher than that of CT,and the difference was statistical y significant(P < 0.05). Conclusion For patients with central lung cancer diagnosis on the basis of CT MRI supplement diagnosis can improve the accuracy of diagnosis,can provide a more reliable reference for clinical treatment.%目的:探究 CT 诊断中心型肺癌的准确性,同时对 MRI 补充诊断的临床意义进行全面的分析。方法选取我院2015年3月2日~2015年11月2日收治的150例中心型肺癌患者为研究对象,对所有患者采取 CT 检查诊断。在 CT 检查的基础上对患者采用 MRI 补充诊断,对两种不同的诊断方法的准确性进行比较分析。结果仅对患者采用 CT 诊断,准确率为79.35%。在此基础上对患者进行 MRI 补充诊断,准确率为94.62%。进行 MRI 补充诊断的准确率高于 CT 诊断的准确率,差异具有统计学意义(P <0.05)。结论对中心型肺癌患者在 CT 诊断的基础上进行 MRI 补充诊断可以有效地提高诊断的准确性,可以给临床治疗提供更加可靠参考依据。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号